trial

Efficacy of Social Cognition Training in Schizophrenia

NCTId NCT00587561
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 51 (actual)
Sponsored by VA Connecticut Healthcare System
Primary completion 2013-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
51 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
None
Start
2008-01
Primary completion
2013-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Social Cognition Interaction TrainingWLC

Sponsors

VA Connecticut Healthcare SystemLead Sponsor

Investigators

1
Joanna Fiszdon, Ph.D.Principal Investigator

Sites

2 total
New Haven, United StatesWest Haven, United States

Facts & assertions

4 sourced
Enrollment
51
Phase
NA
Primary Completion Date
2013-12
Status
COMPLETED
relationships
The graph out of here
drug
Social Cognition Interaction Training
drug
WLC
drug
lead_sponsor
VA Connecticut Healthcare System
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Joanna Fiszdon, Ph.D.
person